ERRFI1: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
 
m (Bot: HTTP→HTTPS)
Line 1: Line 1:
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{Infobox_gene}}
{{PBB_Controls
'''ERBB receptor feedback inhibitor 1''' is a [[protein]] that in humans is encoded by the ''ERRFI1'' [[gene]].<ref name="pmid10749885">{{cite journal | vauthors = Makkinje A, Quinn DA, Chen A, Cadilla CL, Force T, Bonventre JV, Kyriakis JM | title = Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK. A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stress | journal = J Biol Chem | volume = 275 | issue = 23 | pages = 17838–17847 |date=Jul 2000 | pmid = 10749885 | pmc =  | doi = 10.1074/jbc.M909735199 }}</ref><ref name="pmid2780291">{{cite journal | vauthors = Chrapkiewicz NB, Davis CM, Chu DT, Caldwell CM, Granner DK | title = Rat gene 33: analysis of its structure, messenger RNA and basal promoter activity | journal = Nucleic Acids Res | volume = 17 | issue = 16 | pages = 6651–6667 |date=Oct 1989 | pmid = 2780291 | pmc = 318357 | doi =10.1093/nar/17.16.6651  }}</ref><ref name="pmid12226756">{{cite journal | vauthors = Fiorini M, Ballaro C, Sala G, Falcone G, Alema S, Segatto O | title = Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control | journal = Oncogene | volume = 21 | issue = 42 | pages = 6530–6539 |date=Sep 2002 | pmid = 12226756 | pmc = | doi = 10.1038/sj.onc.1205823 }}</ref><ref name="pmid11003669">{{cite journal | vauthors = Fiorentino L, Pertica C, Fiorini M, Talora C, Crescenzi M, Castellani L, Alema S, Benedetti P, Segatto O | title = Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain | journal = Mol Cell Biol | volume = 20 | issue = 20 | pages = 7735–7750 |date=Oct 2000 | pmid = 11003669 | pmc = 86354 | doi =10.1128/MCB.20.20.7735-7750.2000  }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: ERRFI1 ERBB receptor feedback inhibitor 1| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=54206| accessdate = }}</ref>
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
 
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =  
| Name = ERBB receptor feedback inhibitor 1
| HGNCid = 18185
| Symbol = ERRFI1
| AltSymbols =; MIG6; GENE-33; MIG-6; RALT
  | OMIM = 608069
| ECnumber =
| Homologene = 10344
| MGIid = 1921405
| Function = {{GNF_GO|id=GO:0005100 |text = Rho GTPase activator activity}} {{GNF_GO|id=GO:0005515 |text = protein binding}}
| Component = {{GNF_GO|id=GO:0005737 |text = cytoplasm}}  
| Process = {{GNF_GO|id=GO:0006950 |text = response to stress}}
| Orthologs = {{GNF_Ortholog_box
    | Hs_EntrezGene = 54206
    | Hs_Ensembl = ENSG00000116285
    | Hs_RefseqProtein = NP_061821
    | Hs_RefseqmRNA = NM_018948
    | Hs_GenLoc_db =
    | Hs_GenLoc_chr = 1
    | Hs_GenLoc_start = 7994366
    | Hs_GenLoc_end = 8008955
    | Hs_Uniprot = Q9UJM3
    | Mm_EntrezGene = 74155
    | Mm_Ensembl = ENSMUSG00000028967
    | Mm_RefseqmRNA = NM_133753
    | Mm_RefseqProtein = NP_598514
    | Mm_GenLoc_db =
    | Mm_GenLoc_chr = 4
    | Mm_GenLoc_start = 149697719
    | Mm_GenLoc_end = 149712687
    | Mm_Uniprot = Q3TJN8
  }}
}}
'''ERBB receptor feedback inhibitor 1''', also known as '''ERRFI1''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: ERRFI1 ERBB receptor feedback inhibitor 1| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=54206| accessdate = }}</ref>


<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
{{PBB_Summary
| section_title =  
| section_title =  
| summary_text = MIG6 is a cytoplasmic protein whose expression is upregulated with cell growth (Wick et al., 1995). It shares significant homology with the protein product of rat gene-33, which is induced during cell stress and mediates cell signaling (Makkinje et al., 2000; Fiorentino et al., 2000).[supplied by OMIM]<ref name="entrez">{{cite web | title = Entrez Gene: ERRFI1 ERBB receptor feedback inhibitor 1| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=54206| accessdate = }}</ref>
| summary_text = MIG6 is a [[Cytoplasmic]] [[protein]] whose expression is upregulated with cell growth (Wick et al., 1995). It shares significant homology with the protein product of rat gene-33, which is induced during cell stress and mediates cell signaling (Makkinje et al., 2000; Fiorentino et al., 2000).[supplied by OMIM]<ref name="entrez" />
}}
}}
==Interactions==
ERRFI1 has been shown to [[Protein-protein interaction|interact]] with [[Stratifin]]<ref name=pmid15778465>{{cite journal |last=Benzinger |first=Anne |author2=Muster Nemone |author3=Koch Heike B |author4=Yates John R |author5=Hermeking Heiko  |date=Jun 2005 |title=Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer |journal=Mol. Cell. Proteomics |volume=4 |issue=6 |pages=785–795 |publisher= |location = United States| issn = 1535-9476| pmid = 15778465 |doi = 10.1074/mcp.M500021-MCP200 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = }}</ref> and [[CDC42]].<ref name=pmid10749885 />


==References==
==References==
{{reflist|2}}
{{reflist}}
 
==Further reading==
==Further reading==
{{refbegin | 2}}
{{refbegin | 2}}
{{PBB_Further_reading  
{{PBB_Further_reading  
| citations =  
| citations =  
*{{cite journal  | author=Zhang YW, Vande Woude GF |title=Mig-6, signal transduction, stress response and cancer. |journal=Cell Cycle |volume=6 |issue= 5 |pages= 507-13 |year= 2007 |pmid= 17351343 |doi=  }}
*{{cite journal  | vauthors=Zhang YW, Vande Woude GF |title=Mig-6, signal transduction, stress response and cancer |journal=Cell Cycle |volume=6 |issue= 5 |pages= 507–13 |year= 2007 |pmid= 17351343 |doi=10.4161/cc.6.5.3928 }}
*{{cite journal  | author=Chrapkiewicz NB, Davis CM, Chu DT, ''et al.'' |title=Rat gene 33: analysis of its structure, messenger RNA and basal promoter activity. |journal=Nucleic Acids Res. |volume=17 |issue= 16 |pages= 6651-67 |year= 1989 |pmid= 2780291 |doi= }}
*{{cite journal  | vauthors=Wick M, Bürger C, Funk M, Müller R |title=Identification of a novel mitogen-inducible gene (mig-6): regulation during G1 progression and differentiation |journal=Exp. Cell Res. |volume=219 |issue= 2 |pages= 527–535 |year= 1995 |pmid= 7641805 |doi= 10.1006/excr.1995.1261 }}
*{{cite journal  | author=Wick M, Bürger C, Funk M, Müller R |title=Identification of a novel mitogen-inducible gene (mig-6): regulation during G1 progression and differentiation. |journal=Exp. Cell Res. |volume=219 |issue= 2 |pages= 527-35 |year= 1995 |pmid= 7641805 |doi= 10.1006/excr.1995.1261 }}
*{{cite journal  | vauthors=Hackel PO, Gishizky M, Ullrich A |title=Mig-6 is a negative regulator of the epidermal growth factor receptor signal |journal=Biol. Chem. |volume=382 |issue= 12 |pages= 1649–1662 |year= 2002 |pmid= 11843178 |doi=10.1515/BC.2001.200  }}
*{{cite journal  | author=Makkinje A, Quinn DA, Chen A, ''et al.'' |title=Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK. A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stress. |journal=J. Biol. Chem. |volume=275 |issue= 23 |pages= 17838-47 |year= 2000 |pmid= 10749885 |doi= 10.1074/jbc.M909735199 }}
*{{cite journal  | author=Tsunoda T |title=A novel mechanism of nuclear factor kappaB activation through the binding between inhibitor of nuclear factor-kappaBalpha and the processed NH(2)-terminal region of Mig-6 |journal=Cancer Res. |volume=62 |issue= 20 |pages= 5668–71 |year= 2002 |pmid= 12384522 |doi= |name-list-format=vanc| author2=Inokuchi J  | author3=Baba I  | display-authors=| last4=Okumura  | first4=| last5=Naito  | first5=| last6=Sasazuki | first6=T  | last7=Shirasawa  | first7=S  }}
*{{cite journal  | author=Fiorentino L, Pertica C, Fiorini M, ''et al.'' |title=Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain. |journal=Mol. Cell. Biol. |volume=20 |issue= 20 |pages= 7735-50 |year= 2000 |pmid= 11003669 |doi}}
*{{cite journal  | vauthors=Saarikoski ST, Rivera SP, Hankinson O |title=Mitogen-inducible gene 6 (MIG-6), adipophilin and tuftelin are inducible by hypoxia |journal=FEBS Lett. |volume=530 |issue= 1–3 |pages= 186–190 |year= 2002 |pmid= 12387890 |doi=10.1016/S0014-5793(02)03475-0 }}
*{{cite journal  | author=Hackel PO, Gishizky M, Ullrich A |title=Mig-6 is a negative regulator of the epidermal growth factor receptor signal. |journal=Biol. Chem. |volume=382 |issue= 12 |pages= 1649-62 |year= 2002 |pmid= 11843178 |doi=  }}
*{{cite journal  | author=Strausberg RL |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–16903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241  |name-list-format=vanc| author2=Feingold EA  | author3=Grouse LH  | display-authors=3  | last4=Derge  | first4=JG  | last5=Klausner  | first5=RD  | last6=Collins  | first6=FS  | last7=Wagner  | first7=L  | last8=Shenmen  | first8=CM  | last9=Schuler | first9=GD }}
*{{cite journal  | author=Fiorini M, Ballarò C, Sala G, ''et al.'' |title=Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control. |journal=Oncogene |volume=21 |issue= 42 |pages= 6530-9 |year= 2002 |pmid= 12226756 |doi= 10.1038/sj.onc.1205823 }}
*{{cite journal  | author=Anastasi S |title=Feedback inhibition by RALT controls signal output by the ErbB network |journal=Oncogene |volume=22 |issue= 27 |pages= 4221–4234 |year= 2003 |pmid= 12833145 |doi= 10.1038/sj.onc.1206516 |name-list-format=vanc| author2=Fiorentino L | author3=Fiorini M  | display-authors=3  | last4=Fraioli  | first4=Rocco  | last5=Sala  | first5=Gianluca  | last6=Castellani  | first6=| last7=Alemà  | first7=Stefano  | last8=Alimandi  | first8=Maurizio  | last9=Segatto  | first9=Oreste }}
*{{cite journal | author=Tsunoda T, Inokuchi J, Baba I, ''et al.'' |title=A novel mechanism of nuclear factor kappaB activation through the binding between inhibitor of nuclear factor-kappaBalpha and the processed NH(2)-terminal region of Mig-6. |journal=Cancer Res. |volume=62 |issue= 20 |pages= 5668-71 |year= 2002 |pmid= 12384522 |doi=  }}
*{{cite journal  | author=Ota T |title=Complete sequencing and characterization of 21,243 full-length human cDNAs |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–45 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285  |name-list-format=vanc| author2=Suzuki Y | author3=Nishikawa T | display-authors=| last4=Otsuki  | first4=Tetsuji  | last5=Sugiyama  | first5=Tomoyasu  | last6=Irie  | first6=Ryotaro  | last7=Wakamatsu | first7=Ai  | last8=Hayashi  | first8=Koji  | last9=Sato  | first9=Hiroyuki }}
*{{cite journal  | author=Saarikoski ST, Rivera SP, Hankinson O |title=Mitogen-inducible gene 6 (MIG-6), adipophilin and tuftelin are inducible by hypoxia. |journal=FEBS Lett. |volume=530 |issue= 1-3 |pages= 186-90 |year= 2002 |pmid= 12387890 |doi=  }}
*{{cite journal  | author=Gerhard DS |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC) |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–2127 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504  | pmc=528928  |name-list-format=vanc| author2=Wagner L  | author3=Feingold EA  | display-authors=| last4=Shenmen  | first4=CM  | last5=Grouse  | first5=LH  | last6=Schuler | first6=| last7=Klein  | first7=SL  | last8=Old  | first8=| last9=Rasooly  | first9=R }}
*{{cite journal | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }}
*{{cite journal  | vauthors=Xu D, Makkinje A, Kyriakis JM |title=Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function |journal=J. Biol. Chem. |volume=280 |issue= 4 |pages= 2924–2933 |year= 2005 |pmid= 15556944 |doi= 10.1074/jbc.M408907200 }}
*{{cite journal  | author=Anastasi S, Fiorentino L, Fiorini M, ''et al.'' |title=Feedback inhibition by RALT controls signal output by the ErbB network. |journal=Oncogene |volume=22 |issue= 27 |pages= 4221-34 |year= 2003 |pmid= 12833145 |doi= 10.1038/sj.onc.1206516 }}
*{{cite journal  | vauthors=Keeton AB, Messina JL |title=Modulation of Elk-dependent-transcription by Gene33 |journal=J. Cell. Biochem. |volume=94 |issue= 6 |pages= 1190–1198 |year= 2005 |pmid= 15696545 |doi= 10.1002/jcb.20370 }}
*{{cite journal  | author=Ota T, Suzuki Y, Nishikawa T, ''et al.'' |title=Complete sequencing and characterization of 21,243 full-length human cDNAs. |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40-5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 }}
*{{cite journal  | author=Benzinger A |title=Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer |journal=Mol. Cell. Proteomics |volume=4 |issue= 6 |pages= 785–795 |year= 2005 |pmid= 15778465 |doi= 10.1074/mcp.M500021-MCP200  |name-list-format=vanc| author2=Muster N  | author3=Koch HB  | display-authors=| last4=Yates Jr  | first4=3rd  | last5=Hermeking  | first5=H }}
*{{cite journal | author=Gerhard DS, Wagner L, Feingold EA, ''et al.'' |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121-7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 }}
*{{cite journal  | author=Anastasi S |title=Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin |journal=Oncogene |volume=24 |issue= 28 |pages= 4540–4548 |year= 2005 |pmid= 15856022 |doi= 10.1038/sj.onc.1208658  |name-list-format=vanc| author2=Sala G  | author3=Huiping C  | display-authors=3  | last4=Caprini  | first4=Elisabetta  | last5=Russo  | first5=Giandomenico  | last6=Iacovelli  | first6=Stefano  | last7=Lucini  | first7=Fabiana  | last8=Ingvarsson  | first8=Sigurdur  | last9=Segatto  | first9=Oreste }}
*{{cite journal | author=Xu D, Makkinje A, Kyriakis JM |title=Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function. |journal=J. Biol. Chem. |volume=280 |issue= 4 |pages= 2924-33 |year= 2005 |pmid= 15556944 |doi= 10.1074/jbc.M408907200 }}
*{{cite journal  | author=Ballarò C |title=Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype |journal=EMBO Rep. |volume=6 |issue= 8 |pages= 755–761 |year= 2006 |pmid= 16007071 |doi= 10.1038/sj.embor.7400458  | pmc=1369136  |name-list-format=vanc| author2=Ceccarelli S  | author3=Tiveron C  | display-authors=3  | last4=Tatangelo  | first4=Laura  | last5=Salvatore  | first5=Anna Maria  | last6=Segatto  | first6=Oreste  | last7=Alemà  | first7=Stefano }}
*{{cite journal | author=Keeton AB, Messina JL |title=Modulation of Elk-dependent-transcription by Gene33. |journal=J. Cell. Biochem. |volume=94 |issue= 6 |pages= 1190-8 |year= 2005 |pmid= 15696545 |doi= 10.1002/jcb.20370 }}
*{{cite journal  | author=Gregory SG |title=The DNA sequence and biological annotation of human chromosome 1 |journal=Nature |volume=441 |issue= 7091 |pages= 315–321 |year= 2006 |pmid= 16710414 |doi= 10.1038/nature04727  |name-list-format=vanc| author2=Barlow KF  | author3=McLay KE  | display-authors=3  | last4=Kaul  | first4=R.  | last5=Swarbreck  | first5=D.  | last6=Dunham  | first6=A.  | last7=Scott  | first7=C. E.  | last8=Howe  | first8=K. L.  | last9=Woodfine  | first9=K. }}
*{{cite journal  | author=Benzinger A, Muster N, Koch HB, ''et al.'' |title=Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. |journal=Mol. Cell Proteomics |volume=4 |issue= 6 |pages= 785-95 |year= 2005 |pmid= 15778465 |doi= 10.1074/mcp.M500021-MCP200 }}
*{{cite journal  | author=Zhang YW |title=Evidence that MIG-6 is a tumor-suppressor gene |journal=Oncogene |volume=26 |issue= 2 |pages= 269–276 |year= 2007 |pmid= 16819504 |doi= 10.1038/sj.onc.1209790 |name-list-format=vanc| author2=Staal B  | author3=Su Y  | display-authors=3  | last4=Swiatek  | first4=P  | last5=Zhao  | first5=P  | last6=Cao  | first6=B  | last7=Resau  | first7=J  | last8=Sigler  | first8=R  | last9=Bronson  | first9=R }}
*{{cite journal  | author=Anastasi S, Sala G, Huiping C, ''et al.'' |title=Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin. |journal=Oncogene |volume=24 |issue= 28 |pages= 4540-8 |year= 2005 |pmid= 15856022 |doi= 10.1038/sj.onc.1208658 }}
*{{cite journal  | author=Ballarò C, Ceccarelli S, Tiveron C, ''et al.'' |title=Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype. |journal=EMBO Rep. |volume=6 |issue= 8 |pages= 755-61 |year= 2006 |pmid= 16007071 |doi= 10.1038/sj.embor.7400458 }}
*{{cite journal  | author=Gregory SG, Barlow KF, McLay KE, ''et al.'' |title=The DNA sequence and biological annotation of human chromosome 1. |journal=Nature |volume=441 |issue= 7091 |pages= 315-21 |year= 2006 |pmid= 16710414 |doi= 10.1038/nature04727 }}
*{{cite journal  | author=Zhang YW, Staal B, Su Y, ''et al.'' |title=Evidence that MIG-6 is a tumor-suppressor gene. |journal=Oncogene |volume=26 |issue= 2 |pages= 269-76 |year= 2007 |pmid= 16819504 |doi= 10.1038/sj.onc.1209790 }}
}}
}}
{{refend}}
{{refend}}


{{protein-stub}}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{WikiDoc Sources}}
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
 
 
{{gene-1-stub}}

Revision as of 00:36, 31 August 2017

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

ERBB receptor feedback inhibitor 1 is a protein that in humans is encoded by the ERRFI1 gene.[1][2][3][4][5]

MIG6 is a Cytoplasmic protein whose expression is upregulated with cell growth (Wick et al., 1995). It shares significant homology with the protein product of rat gene-33, which is induced during cell stress and mediates cell signaling (Makkinje et al., 2000; Fiorentino et al., 2000).[supplied by OMIM][5]

Interactions

ERRFI1 has been shown to interact with Stratifin[6] and CDC42.[1]

References

  1. 1.0 1.1 Makkinje A, Quinn DA, Chen A, Cadilla CL, Force T, Bonventre JV, Kyriakis JM (Jul 2000). "Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK. A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stress". J Biol Chem. 275 (23): 17838–17847. doi:10.1074/jbc.M909735199. PMID 10749885.
  2. Chrapkiewicz NB, Davis CM, Chu DT, Caldwell CM, Granner DK (Oct 1989). "Rat gene 33: analysis of its structure, messenger RNA and basal promoter activity". Nucleic Acids Res. 17 (16): 6651–6667. doi:10.1093/nar/17.16.6651. PMC 318357. PMID 2780291.
  3. Fiorini M, Ballaro C, Sala G, Falcone G, Alema S, Segatto O (Sep 2002). "Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control". Oncogene. 21 (42): 6530–6539. doi:10.1038/sj.onc.1205823. PMID 12226756.
  4. Fiorentino L, Pertica C, Fiorini M, Talora C, Crescenzi M, Castellani L, Alema S, Benedetti P, Segatto O (Oct 2000). "Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain". Mol Cell Biol. 20 (20): 7735–7750. doi:10.1128/MCB.20.20.7735-7750.2000. PMC 86354. PMID 11003669.
  5. 5.0 5.1 "Entrez Gene: ERRFI1 ERBB receptor feedback inhibitor 1".
  6. Benzinger, Anne; Muster Nemone; Koch Heike B; Yates John R; Hermeking Heiko (Jun 2005). "Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer". Mol. Cell. Proteomics. United States. 4 (6): 785–795. doi:10.1074/mcp.M500021-MCP200. ISSN 1535-9476. PMID 15778465.

Further reading